Search clinical trials for: XL784
Total 91 results
-
Symphony Evolution, Inc.CompletedDiabetic Nephropathy | AlbuminuriaUnited States
-
ExelixisCompletedGlioblastoma MultiformeUnited States
-
ExelixisCompletedAstrocytic TumorsUnited States, Canada
-
ExelixisCompletedLymphoma | Cancer | Thyroid CarcinomaUnited States
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Massachusetts General HospitalCompletedLung Cancer | Solid Tumor (Not Breast or Prostate Cancers)United States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
ExelixisCompletedHealthy | Hepatic ImpairmentUnited States
-
ExelixisCompletedHealthy | Renal ImpairmentUnited States
-
ExelixisCompletedThyroid CancerFrance, United Kingdom, United States, Spain, Austria, Israel, Portugal, Saudi Arabia, Netherlands, Greece, Canada, Brazil, Chile, Poland, Italy, Russian Federation, Sweden, Germany, Denmark, India, Switzerland, Belgium, Korea, Republic... and more
-
Dana-Farber Cancer InstituteExelixisTerminatedSkin Cancer | Merkel Cell CarcinomaUnited States
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
ExelixisActive, not recruitingMedullary Thyroid CancerAustralia, France, Israel, Spain, Russian Federation, Netherlands, Hungary, Korea, Republic of, Croatia, Italy, Canada, Poland, Romania, Sweden
-
ExelixisCompletedCancer | Solid TumorsUnited States, Taiwan, Belgium, Israel, United Kingdom
-
Bristol-Myers SquibbCompleted
-
Massachusetts General HospitalCompletedProstate AdenocarcinomaUnited States
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
Edwin Posadas, MDCompletedProstate CancerUnited States
-
TakedaCompletedAdvanced Hepatocellular CarcinomaJapan
-
TakedaCompletedAdvanced Renal Cell CarcinomaJapan
-
University of WashingtonNational Cancer Institute (NCI); Prostate Cancer FoundationTerminatedRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
ExelixisIpsenActive, not recruitingDifferentiated Thyroid CancerHong Kong, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, ... and more
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); ExelixisActive, not recruitingRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8United States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell AdenocarcinomaUnited States
-
Baptist Health South FloridaExelixisRecruiting
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Osteosarcoma | Ewing Sarcoma | Recurrent Renal Cell Carcinoma | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Osteosarcoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Ewing Sarcoma | Recurrent Osteosarcoma | Stage III Osteosarcoma AJCC v7 | Stage IV Osteosarcoma AJCC v7 | Stage IVA Osteosarcoma AJCC v7 | Stage IVB Osteosarcoma AJCC v7 | Metastatic Osteosarcoma | Metastatic Ewing Sarcoma | Unresectable Ewing Sarcoma | Unresectable OsteosarcomaFrance
-
ExelixisCompletedRenal Cell Carcinoma | Papillary Thyroid Cancer | Follicular Thyroid Cancer | Huerthle Cell Thyroid CancerUnited States
-
ExelixisCompletedHepatocellular CarcinomaBelgium, Hong Kong, Korea, Republic of, Canada, France, Taiwan, United States, Germany, Spain, United Kingdom, Singapore, Australia, Italy, Netherlands, Poland, Turkey, Ireland, New Zealand, Romania
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland PheochromocytomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Endometrial Adenosquamous... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
ExelixisCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Fox Chase Cancer CenterExelixisRecruitingMetastatic Renal Cell Carcinoma | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
ExelixisCompletedRenal Cell CarcinomaUnited States, Belgium, Spain, Taiwan, Canada, Germany, Korea, Republic of, France, Austria, Chile, Australia, Hungary, Russian Federation, Italy, Turkey, Netherlands, Sweden, United Kingdom, Czechia, Ireland, Slovakia, Argentina, D... and more
-
Mark SteinBristol-Myers Squibb; ExelixisRecruitingCYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)Kidney Cancer | Renal Cell CarcinomaUnited States
-
ExelixisCompletedGlioblastoma | Gliosarcoma | Giant Cell GlioblastomaUnited States
-
M.D. Anderson Cancer CenterExelixisWithdrawnHepatocellular Carcinoma | Liver CancerUnited States
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
University of WashingtonExelixisTerminatedAdvanced Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular CarcinomaUnited States
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; ExelixisCompletedLocally Advanced Hepatocellular CarcinomaUnited States
-
Providence Health & ServicesBristol-Myers Squibb; ExelixisActive, not recruitingRefractory Cutaneous MelanomaUnited States
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States